Thermo Fisher Scientific (TMO) Tops Q1 EPS by 7c; Boosts FY12 Outlook
Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $1.17, $0.07 better than the analyst estimate of $1.10. Revenue for the quarter came in at $3.1 billion versus the consensus estimate of $2.97 billion.
Thermo Fisher Scientific sees FY2012 EPS of $4.71-$4.83, versus prior guidance of $4.67-$4.82 and the consensus of $4.77. Thermo Fisher Scientific sees FY2012 revenue of $12.27-$12.43 billion, versus prior guidance of $12.15-$12.35 billion and the consensus of $12.33 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Thermo Fisher Scientific sees FY2012 EPS of $4.71-$4.83, versus prior guidance of $4.67-$4.82 and the consensus of $4.77. Thermo Fisher Scientific sees FY2012 revenue of $12.27-$12.43 billion, versus prior guidance of $12.15-$12.35 billion and the consensus of $12.33 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.